Effect of galanthamine on memory and quality of life in patients with vascular dementia

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 16, 2004, Pages 3022-3023

  Xian, Ming Jian ^a   Jiang, Xian Di ^a   Yang, Zhi ^a   Li, Chao Mao ^a   Yuan, Li ^a   Fang, Ling ^a   Lan, Song ^a   Lei, Jian Ming ^a   Chen, Hai ^a   Liao, Geng ^a  

^a MAOMING PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROLYSIN; GALANTAMINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; MEMORY; MULTIINFARCT DEMENTIA; QUALITY OF LIFE; RATING SCALE; STATISTICAL SIGNIFICANCE;

EID: 3543052816     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chinese source. 2003,9(3):165-6
2. Chinese source. 2003, 7(7):1098-9
3. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42 (6):1185-93
4. Chinese source. 2003, 7(28):3848-9
5. Ueda K, Kawano H, Hasuo Y, et al. Prevalence and etiology of dementia in a Japanese community. Stroke 1992; 23 (6):798-803
6. Kase CS, Wolf PA, Kelly-Hayes M, et al. Intellectual decline after stroke: the Framingham Study. Stroke 1998; 29 (4): 805-12
7. Censori B, Manara O, Agostinis C, et al. Dementia after first stroke. Stroke 1996;27(7):1205-10
8. Kiyohara Y. Prevalence, incidence, and risk factors of vascular dementia: the Hisayama study. Rinsho Shinkeigaku 1999; 39(1):47-9
9. Woo JI, Lee JH, Yoo KY, et al. Prevalence estimation of dementia in a rural area of Korea. J Am Geriatr Soc 1998;46 (8):983-7
10. Chinese source. 1999,3:43
11. Chinese source. 2003, 7(16):2270-1
12. Tohgi H, Abe T, Kimura M, et al. Cerebrospinal fluid acetyl- choline and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 1996; 103 (10): 1211-20
13. Chinese source. 1997, 5(3):165-7
14. Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359(9314):1283-90